HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Legacy Consumer Health Firms Invest To Compete In Startups' Realm: E-Commerce

This article was originally published in The Rose Sheet

Executive Summary

J&J, Colgate, P&G and Church & Dwight look to e-commerce to regain market share from smaller, nimble consumer health brands and digital-based retail startups, executives from the firms say at Barclays Global Consumer Staples conference.

You may also be interested in...

After Saving Brandless From Closing, Investment Group Ends $3 Flat Pricing, Adds $118M Funding

Clarke Capital led $118m equity and debt financing round for Brandless after acquiring it a year ago. Brandless was prepared to close, saying the “fiercely competitive direct-to-consumer market” wasn’t sustainable for its business model, before Clarke acted in June 2020.

DTC Men’s Health Product Brand Roman Reaches In-Store Sales With Supplements Sold At Walmart

A month after closing its largest funding round, Roman Health' says its daily vitamins and supplements for heart health, stress relief, testosterone support, prostate health and a multivitamin will be available in Walmart stores and in the retail giant’s e-commerce platform on 1 May.

Blooming For Spring: P&G My Black Is Beautiful, Dollar General Root To End! Hair Products

My Black is Beautiful hair care expands with Blue Ginger six-product line for scalp and hair nourishment, rolling out in Sally Beauty, says P&G. Retail chain Dollar General expands its private label offerings with hair care line Root to End!

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts